Puma Biotechnology Stock Story
| PBYI Stock | USD 4.99 0.18 3.48% |
Under 66% of Puma Biotechnology's investor base is looking to short. The analysis of the overall investor sentiment regarding Puma Biotechnology suggests that many traders are alarmed. Puma Biotechnology's investor sentiment overview provides quick insight into current market opportunities from investing in Puma Biotechnology. The current market sentiment, together with Puma Biotechnology's historical and current headlines, can help investors time the market. In addition, many technical investors use Puma Biotechnology stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Puma Biotechnology stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Puma daily returns and investor perception about the current price of Puma Biotechnology as well as its diversification or hedging effects on your existing portfolios.
Puma |
Requested story not found. it has been either deleted or moved. View all stories for Puma Biotechnology.
Puma Biotechnology Latest Timeline
Puma Biotechnology is listed for 4.99. The company reported the previous year's revenue of 235.64 M. Net Income was 21.59 M with profit before overhead, payroll, taxes, and interest of 172.94 M.Check out Puma Biotechnology Hype Analysis, Puma Biotechnology Correlation and Puma Biotechnology Performance. For more detail on how to invest in Puma Stock please use our How to Invest in Puma Biotechnology guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Puma Stock analysis
When running Puma Biotechnology's price analysis, check to measure Puma Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Puma Biotechnology is operating at the current time. Most of Puma Biotechnology's value examination focuses on studying past and present price action to predict the probability of Puma Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Puma Biotechnology's price. Additionally, you may evaluate how the addition of Puma Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is Puma Biotechnology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Puma Biotechnology. If investors know Puma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Puma Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.78) | Earnings Share 0.45 | Revenue Per Share 4.999 | Quarterly Revenue Growth 0.099 | Return On Assets 0.0919 |
The market value of Puma Biotechnology is measured differently than its book value, which is the value of Puma that is recorded on the company's balance sheet. Investors also form their own opinion of Puma Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Puma Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Puma Biotechnology's market value can be influenced by many factors that don't directly affect Puma Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Puma Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Puma Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Puma Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.